Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Eli Lilly reported strong earnings for the second quarter, beating on the top and bottom lines. Disappointing trial results ...

In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.

US Stock Market prediction - Both the S&P 500 and the Nasdaq were on track for their best week in over a month.

In May, it announced it would acquire SiteOne Therapeutics, a drugmaker with a promising investigational medicine for pain.

When one reads the premise of Weapons and thinks about the title of this acclaimed horror movie from director Zach Cregg, it ...

Eli Lilly’s orforglipron cut body weight to a lesser extent than rival Novo Nordisk’s semaglutide, falling into analysts’ ...

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...